We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

917 hedge funds and large institutions have $44.1B invested in Thermo Fisher Scientific in 2014 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 329 increasing their positions, 365 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more call options, than puts

Call options by funds: $188M | Put options by funds: $114M

26% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 50

16% more funds holding in top 10

Funds holding in top 10: 5867 (+9)

2% more capital invested

Capital invested by funds: $43.2B → $44.1B (+$891M)

1% more funds holding

Funds holding: 911917 (+6)

10% less repeat investments, than reductions

Existing positions increased: 329 | Existing positions reduced: 365

1.57% less ownership

Funds ownership: 92.53%90.96% (-1.6%)

Holders
917
Holders Change
+6
Holders Change %
+0.66%
% of All Funds
26.6%
Holding in Top 10
67
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+15.52%
% of All Funds
1.94%
New
63
Increased
329
Reduced
365
Closed
50
Calls
$188M
Puts
$114M
Net Calls
+$74M
Net Calls Change
+$6.14M
Name Holding Trade Value Shares
Change
Change in
Stake
JEW
526
Jamison Eaton & Wood
New Jersey
$1.97M +$9.12K +75 +0.5%
NB
527
Norinchukin Bank
Japan
$1.95M +$137K +1,130 +8%
MFS
528
Monetta Financial Services
Illinois
$1.95M
DL
529
Delta Lloyd
Netherlands
$1.94M +$1.7K +14 +0.1%
RFS
530
Rockefeller Financial Services
New York
$1.93M -$183K -1,509 -9%
APFBOT
531
Amica Pension Fund Board of Trustees
Rhode Island
$1.92M
QI
532
QS Investors
New York
$1.91M -$13.5M -111,200 -88%
MYLI
533
Meiji Yasuda Life Insurance
Japan
$1.91M +$68.6K +564 +4%
SSIA
534
Spero-Smith Investment Advisers
Ohio
$1.88M -$882K -7,250 -32%
MA
535
MUFG Americas
New York
$1.81M +$722K +5,939 +65%
EP
536
Edgestream Partners
New Jersey
$1.8M -$1.79M -14,761 -50%
AHS
537
Aspiriant Holdings S3
California
$1.79M -$56.4K -464 -3%
CIM
538
Calvert Investment Management
Maryland
$1.78M +$1.32M +10,893 +290%
Flossbach Von Storch
539
Flossbach Von Storch
Germany
$1.78M -$267K -2,200 -13%
ROTUOC
540
Regents of the University of California
California
$1.78M +$1.78M +14,600 New
PC
541
Polar Capital
United Kingdom
$1.77M +$361K +2,973 +26%
SNBOSD
542
Security National Bank of So Dak
Iowa
$1.75M -$33.8K -278 -2%
CWP
543
Capital Wealth Planning
Florida
$1.74M
BOTW
544
Bank of the West
California
$1.7M +$1.07M +8,778 +168%
MS
545
Marshall & Sullivan
Washington
$1.69M +$363K +2,983 +27%
MERSOM
546
Municipal Employees' Retirement System of Michigan
Michigan
$1.68M +$36.5K +300 +2%
AC
547
Allstate Corporation
Illinois
$1.66M +$344K +2,833 +26%
RBA
548
Richard Bernstein Advisors
New York
$1.63M
PFBT
549
Parkside Financial Bank & Trust
Missouri
$1.63M -$11.1K -91 -0.7%
ARC
550
Absolute Return Capital
Massachusetts
$1.63M +$754K +6,204 +86%

TMO Hedge Fund Activity: Q3 2014 in Review

917 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2014, worth a combined $44.1B — up 2.1% from $43.2B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new TMO positions and 50 closed out — a net gain of 13 holders — while 329 added to existing stakes and 365 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $288M. The largest seller was Paulson & Co, exiting entirely with an estimated $381M sold.

  • 917 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2014, up from 911 in Q2 2014.
  • Funds reported $44.1B of Thermo Fisher Scientific stock for Q3 2014, up 2.1% quarter-over-quarter.
  • 63 funds opened new Thermo Fisher Scientific positions in Q3 2014 and 50 closed out, a net change of +13 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2014 was Wellington Management Group, an estimated $288M added.
  • The largest Thermo Fisher Scientific seller in Q3 2014 was Paulson & Co, an estimated $381M sold.

Based on aggregated 13F filings for Q3 2014.